Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. Clinical Medicine / 臨床醫學研究所
  4. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19)
 
  • Details

Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19)

Journal
Journal of Biomedical Science
Journal Volume
27
Journal Issue
1
Pages
72
Date Issued
2020
Author(s)
Chang F.-Y.
Chen H.-C.
PEI-JER CHEN  
Ho M.-S.
Hsieh S.-L.
Lin J.-C.
Liu F.-T.
Sytwu H.-K.
DOI
10.1186/s12929-020-00663-w
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085999594&doi=10.1186%2fs12929-020-00663-w&partnerID=40&md5=e391f4fad861bd6fbf18b282f2529c83
https://scholars.lib.ntu.edu.tw/handle/123456789/568298
Abstract
On March 11, 2020, the World Health Organization declared the worldwide spread of the infectious disease COVID-19, caused by a new strain of coronavirus, SARS-CoV-2, as a pandemic. Like in all other infectious diseases, the host immune system plays a key role in our defense against SARS-CoV-2 infection. However, viruses are able to evade the immune attack and proliferate and, in susceptible individuals, cause severe inflammatory response known as cytokine storm, particularly in the lungs. The advancement in our understanding of the mechanisms underlying the host immune responses promises to facilitate the development of approaches for prevention or treatment of diseases. Components of immune system, such as antibodies, can also be used to develop sensitive and specific diagnostic methods as well as novel therapeutic agents. In this review, we summarize our knowledge about how the host mounts immune responses to infection by SARS-CoV-2. We also describe the diagnostic methods being used for COVID-19 identification and summarize the current status of various therapeutic strategies, including vaccination, being considered for treatment of the disease. ? 2020 The Author(s).
Subjects
Adaptive immunity; Antibody-dependent enhancement; COVID-19; Cytokine storm; Innate immunity; SARS-CoV; SARS-CoV-2; Vaccine
SDGs

[SDGs]SDG3

Other Subjects
Chinese drug; cytokine; interferon; lianhuaqingwen; recombinant alpha interferon; ribavirin; unclassified drug; adaptive immunity; adverse event; antibody dependent enhancement; antiviral activity; clinical feature; coronavirus disease 2019; cytotoxic T lymphocyte; dendritic cell; diagnostic test; epidemic; herd immunity; human; humoral immunity; immune response; immunopathology; immunotherapy; infection prevention; infection rate; innate immunity; major histocompatibility complex; medical technology; Middle East respiratory syndrome coronavirus; plasma; priority journal; reverse transcription polymerase chain reaction; Review; Severe acute respiratory syndrome coronavirus 2; vaccination; virus entry; virus replication; virus transmission; Betacoronavirus; coronavirus disease 2019; Coronavirus infection; devices; diagnostic procedure; immunology; pandemic; physiology; virology; virus pneumonia; Betacoronavirus; Coronavirus Infections; Diagnostic Techniques and Procedures; Humans; Pandemics; Pneumonia, Viral
Publisher
BioMed Central Ltd.
Type
Review

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science